Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
237 Leser
Artikel bewerten:
(1)

Regener Eyes: Regener-Eyes(R) Gives Back this Holiday Season

Regener-Eyes LLC - a subsidiary of Regenerative Processing Plant Inc. proudly announces a holiday campaign in support of Prevent Blindness and their ongoing mission to preserve sight.

PALM HARBOUR, FL / ACCESSWIRE / January 4, 2021 / The professionals at Regener-Eyes® LLC continue to give back this holiday season, having recently launching a campaign in support of Prevent Blindness - a non-profit eye health organization headquartered in Chicago, Illinois.

Now through Jan. 15, 2021, Regener-Eyes® will donate $1 for every purchase of either Regener-Eyes® LITE or Regener-Eyes® Professional Strength eye drops. The company plans to launch the holiday campaign among Optometrists and Ophthalmologists that currently script and/ or stock their product.

As one of the nation's oldest non-profit eye health organizations, Prevent Blindness is founded on more than 110 years of leadership, programming, partnerships, and policy development.

"Our mission is to enhance awareness about our organization while working to broaden the impact of improved vision and eye health," states Jeff Todd, the president and CEO of Prevent Blindness. "We would like to formally thank those at Regener-Eyes for their time, efforts, and ongoing commitment to the cause. We will continue to make a positive difference in 2021 and beyond."

Regener-Eyes®, a first in class biologic eye drop, composed of anti-inflammatory cytokines and growth factors. These types of proteins have been shown to reduce inflammation while helping to stimulate the ocular surface to heal, repair, and regenerate.

"It's an honor to be able to give back this holiday season," says Dr. Randall Harrell, CEO and Founder of Regener-Eyes®, LLC. "The professionals at Prevent Blindness continue to go above and beyond in their efforts to preserve sight. We hope that the organization's reach will only grow from here."

To learn more about Regener-Eyes® biologic eye drops, visit the Regener-Eyes® website at www.mydryeyes.org.

About Regener-Eyes®

Regener-Eyes® is a leading biologic eye drop made of anti-inflammatory cytokines and growth factors- proteins known to reduce inflammation and stimulate the ocular surface to heal, repair, and regenerate. With a strong focus on regenerative medicine, the professionals at Regener-Eyes® claim that the product may be a solution for those who are currently unresponsive to their eye drug or are amniotic membrane intolerant.

For more information on our first in class biologic eye drop, please visit www.mydryeyes.org, follow us on Instagram, like us on Facebook, and connect with us on LinkedIn.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs, and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information or to contribute to the sight-saving fund, call 1-800-331-2020. Or visit us on the Web at preventblindness.org or facebook.com/preventblindness.

CONTACT:

Regener-Eyes®, LLC
Heidi Hart Pukas
heidi.pukas@regenerativeplant.org

Prevent Blindness
Sarah Hecker
shecker@preventblindness.org

SOURCE: Regener-Eyes®, LLC



View source version on accesswire.com:
https://www.accesswire.com/622982/Regener-EyesR-Gives-Back-this-Holiday-Season

© 2021 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.